Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: Ethnicity, systemic manifestations, and HLA genotype data

Ocular Immunology and Inflammation

Volumn 16, Issue 1-2, 2008, Pages 3-8

  Abad, S ^a,c   Monnet, D ^b   Caillat Zucman, S ^b   Mrejen, S ^b   Blanche, P ^b   Chalumeau, M ^b   Mouthon, L ^b   Dhote, R ^a   Brezin A P ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

Ethnicity; HLA DRB1; Uveomeningoencephalitides; Vitiligo; Vogt Koyanagi Harada disease

Indexed keywords

HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; ETHNICITY; FEMALE; FRANCE; GENE FREQUENCY; GENOTYPE; HLA SYSTEM; HUMAN; IRIDOCYCLITIS; MALE; NEUROLOGIC DISEASE; SKIN DISEASE; UVEITIS; VITILIGO; VOGT KOYANAGI SYNDROME;

ADULT; ALLELES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HISPANIC AMERICANS; HLA-DR ANTIGENS; HUMANS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; SKIN DISEASES; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 41649084542     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940801923895     Document Type: Article

References (27)

1. Kondo I, Yamagata K, Yamaki K, et al. Analysis of the candidate antigen for Harada's disease. Nippon Ganka Gakkai Zasshi - Acta Societatis Ophtalmologicae Japonicae. 1994;98:596-603.
2. Sugita S, Sagawa K, Mochizuki M, et al. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol. 1996;8:799-803.
3. Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanaghi-Harada disease. Br J Ophthalmol. 1996;80:1002-1008.
4. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada Syndrome. Surv Ophthalmol. 1995;39:265-292.
5. Numaga J, Matsuki K, Tokunaga K, et al. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 1991;32:1958-1961.
6. Weisz JM, Holland GN, Roer LN, et al. Association between Vogt-Koyanagi-Harada sydrome and HLA-DR1 and HLA-DR4 in hispanic patients living in southern California. Ophthalmology 1995;102:1012-1015.
7. Shindo Y, Ohno S, Yamamoto T, et al. Complete association of HLA-DRB1*04 and DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Human Immunol. 1994;39:169-176.
8. Guenoun JM, Parc C, Dhote R, et al. Vogt-Koyanagi-Harada Disease: clinical features, therapy and long-term visual outcome in a Caucasian and African population. J Fr Ophtalmol. 2004;27:1013-1016.
9. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-652.
10. Jabs DA, Nussenblatt RB, Rosembaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140:509-516.
11. Ohno S, Char DH, Kimura SJ, et al. Vogt-Koyanagi-Harada's syndrome. Am J Ophthalmol. 1977;83:735-740.
12. Beniz J, Forster DJ, Lean JS, et al. Variations in clinical features of the Vogt-Koyanagi-Harada Syndrome. Retina. 1991;11:275-280.
13. Nussenblatt RB. Clinical studies of Vogt-kayanagi-Harada's disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol. 1988;32:330-333.
14. Belfort Junior R, Nishi M, Hayashi S, et al. Vogt-Koyanagi-Harada's disease in Brazil. Jpn J Ophthalmol. 1988;32:344-347.
15. Sheu SJ. Update on uveomeningoencephalitides. Curr Opin Neurol. 2005;18:323-329.
16. Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007:21:33-39.
17. Sugiura S. Vogt-Koyanagi-Harada disease. Jpn. J Ophthalmol. 1978;22:9-35.
18. Read RW, Rao NA. Utility of existing Vogt-Koyanagi-Harada syndrome criteria at initial evaluation of individual patient: a retrospective analysis. Ocular Immunol Inflamm. 2000;8:227-234.
19. Kitamura M, Takami K, Kitachi N, et al. Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol. 2005;139:1080-1085.
20. Yang P, Ren Y, Li B, et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606-614.
21. Khairallah M, Zaouali S, Messaoud R, et al. The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa. Int Ophthalmol. 2007;27:125-130.
22. Zhao M, Jiang Y, Abrahams IW. The association of HLA antigens with VKH syndrome in a Han Chinese population. Arch Ophthalmol. 1991;109:368-370.
23. Kim MH, Seong MC, Kwak NH, et al. Association of HLA with Vogt-Koyanagi-Harada Syndrome in Koreans. Am J Ophthalmol. 2000;129:173-177.
24. Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLA-DRB1* 0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol. 1998;59:183-188.
25. Pivetti-Pezzi P, Accorinti M, Colabelli-Gisoldi RA, et al. Vogtkoyanagi-Harada disease and HLA type in Italian patients. Am J Ophthalmol. 1996;122:889-891.
26. Shindo Y, Inoko H, Yamamoto T, et al. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994;78:223-226.
27. Damico FM, Cunha-Neto E, Goldberg AC, et al. T-Cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and negative Vogt-Koyanagi-Harada Uveitis. Invest Ophthalmol Vis Sci. 2005;46:2465-2471.